Justin Anderson, MD

[PDBrown @PDBrownOnc]

Randomized Trial 1 Yr Seizure prophylaxis after glioma surgery
1 Yr Seizure 47% levetiracetam vs 41% no prophylaxis
1 Yr OS 59% levetiracetam vs 69% no prophylaxis
No proven role seizure prophylaxis in glioma
https://t.co/PUFitBxUYU

[Chris Jackson, MD, MS @Chris_JacksonMD]

Our work identifying a new spinal cord constraint for spine SBRT was published yesterday in @JAMAOnc @DanHigginsonMD.

Here, a thread:

https://t.co/exXAnNXZjK

[Brendon Stiles @BrendonStilesMD]

Have to admit that I am a bit disappointed watching many #RadOnc like, retweet, & embrace this study without pointing out critical flaws - particularly after the whole hullabaloo w/ the IRRADIaTE radiation complications paper. Pretty classic example of confirmation bias...

[Brendon Stiles @BrendonStilesMD]

I feel compelled to circle back to this "bombshell" revelation posted on CTSNET. I don't intend to criticize my surgical colleagues, but I fail to understand the rationale for this webinar or how they reached the supposed "bombshell" conclusions...
https://t.co/VOCwkySAwj

[Nikita Sushentsev @NikiSushentsev]

1/2 Just published in @JAMAOnc: 15-year outcomes of Active Monitoring, Surgery, and Radiotherapy for cribriform-positive and cribriform-negative prostate cancer in the ProtecT trial. Secondary analysis based on centralised biopsy review🔬 Article: https://t.co/qfCzYTmevN

[Jason Ryan @jasonryanmd]

Here’s a nice analysis of 2.5M children about Tylenol and autism. The study found a small association between tylenol use in pregnancy and autism, but the association went away in sibling analysis. In sibling analysis you compare children born to the same mother where one child was exposed to Tylenol but not the other. This is a better comparison because genetics are similar between siblings whereas they differ greatly in non siblings from different families. Bottom line: no increased risk of autism with tylenol use in a huge population analysis. https://t.co/JyodtiSwWC

[Steve McGuire @sfmcguire79]

Ezra Klein on Charlie Kirk:

“You can dislike much of what Kirk believed and the following statement is still true: Kirk was practicing politics in exactly the right way. He was showing up to campuses and talking with anyone who would talk to him. He was one of the era’s most effective practitioners of persuasion. When the left thought its hold on the hearts and minds of college students was nearly absolute, Kirk showed up again and again to break it. Slowly, then all at once, he did. College-age voters shifted sharply right in the 2024 election.

“That was not all Kirk’s doing, but he was central in laying the groundwork for it. I did not know Kirk and I am not the right person to eulogize him. But I envied what he built. A taste for disagreement is a virtue in a democracy. Liberalism could use more of his moxie and fearlessness. In the inaugural episode of his podcast, Gov. Gavin Newsom of California hosted Kirk, admitting that his son was a huge fan. What a testament to Kirk’s project.”

“Kirk and I were on different sides of most political arguments. We were on the same side on the continued possibility of American politics. It is supposed to be an argument, not a war; it is supposed to be won with words, not ended through bullets. I wanted Kirk to be safe for his sake, but I also wanted him to be safe for mine, and for the sake of our larger shared project. The same is true for Shapiro, for Hoffman, for Hortman, for Thompson, for Trump, for Pelosi, for Whitmer. We are all safe, or none of us are.”

[Dan Trifiletti, MD @DanTrifMD]

🚨Big news🚨

After years of planning 📖 and preparation 🏗️, we have now expanded our radonc department’s footprint, capacity, and technology. We’re excited to discover the biology 🧪 and clinical impact ♥️ of carbon ion therapy in the New World! 🌎

[Daniel E Spratt @DrSpratticus]

You be the judge:

55yo FIR who wants cure with QOL.

@AmarUKishan @DrAndrewLoblaw @HimanshuNagarMD @jryckman3 @freddyeescorcia @TylerSbrt

[Mayo Clinic Florida Radiation Oncology Residency @MayoFL_RORes]

Future Rad Oncs, we’re calling you 📞‼️

A #radonc away rotation @MayoClinicFlorida means a month of learning from our incredible faculty, exploring our beautiful campus, and soaking up the sunshine in Jacksonville, Florida! 🌴☀️🌊

🚨 Apply via VSLO or [email protected]🚨

[Icro Meattini @Icro_Meattini]

We’ve just enrolled the last patient in the EUROPA trial!

926 patients recruited over 4 years across 20 centres

An infinite thank you to all patients, investigators, and caregivers who made this incredible journey possible ❤️

@OncoAlert #OncoAlert #BreastCancer #radonc #medonc

[Roger Seheult, MD @RogerSeheult]

Math question: Which line(s) are not responsible for increasing costs in healthcare.

Hint: I took old math.

[John Suh @DrJohnSuh]

Looking forward to ⁦@HaleyPerlow⁩ talk on Management of CNS tumors as part of the 26th Annual Best of Radiation Oncology course. ⁦@DrSpratticus⁩ @RadOncUH⁩ ⁦@caseccc⁩

[ASTRO @ASTRO_org]

ASTRO President Sameer Keole, MD, FASTRO, initiates a new video series, the ASTRO President’s Corner! This week, Dr. Keole discusses the organizational structure of ASTRO, detailing the six Councils and makeup of the Board of Directors, and shares a brief history of the Society. https://t.co/8wDn4JrzQV
@SameerKeoleMD

[Sushil @Sushilberiwal]

This is what we thought would be but didn’t have evidence like this to support . Excellent work @Icro_Meattini and team @CShahMD @ErinGillespieMD

[NonsparseOncologist @5_utr]

‼️ EUROPA interim

Ph3 RCT 70+ y/o low risk breast cancer -> BCS -> adjuvant endocrine only vs adjuvant APBI only

APBI has better HRQoL than endocrine tx, adj mean difference 6.39 (0.14-12.65)

0 IBTR, LRR, or DM events!!

🤩 #SABCS24

[Jeff Ryckman @jryckman3]

Dear @Humana, my patient with oligometastatic prostate cancer (CHAARTED-defined) qualifies for prostate-directed radiotherapy per STAMPEDE Arm H—a Phase III trial showing overall survival benefit. Despite 3D radiotherapy approval, IMRT was denied. I was denied peer-to-peer review & unable to submit a 3D vs. IMRT comparison during appeal. Offering 3D risks harm to the patient, as STAMPEDE notes: "Toxicity...could be further reduced by contemporary IMRT techniques." This denial impedes medically necessary care.

I submitted a detailed appeal citing Phase III trial data proving the overall survival benefit and necessity of this treatment, yet no discussion with a board-certified radiation oncologist was offered. I won’t stop fighting until my patient receives the care they deserve. #FixPriorAuth

https://t.co/q7nC52MrgS

[Emma B. Holliday MD @DrEmmaHolliday]

November is Pancreatic Cancer Awareness Month!💜

If you feel called to do so- please consider making a donation to @Run4Purple. I am running on their charity team in the @bostonmarathon #Boston129 next spring!
#purplehairDOcare

https://t.co/3uNeW9R7kj